単位投与量製造市場：製品、調達先、エンドユーザー別-2025-2030年の世界予測

単位投与量製造市場は、2023年に233億4,000万米ドルと評価され、2024年には276億1,000万米ドルに達すると予測され、CAGR 18.76%で成長し、2030年には778億1,000万米ドルに達すると予測されています。

単位投与量製造では、事前に計量された個別用量の医薬品を製造することが含まれ、ヘルスケアおよび製薬業界では不可欠な要素となっています。その必要性は、特に病院や長期介護施設において、効果的な投薬管理、患者の安全性、処方された治療法の順守に対する需要の高まりによって強調されています。用途は医薬品にとどまらず、栄養補助食品や一般用医薬品にまで広がり、単位投与量を活用して精度と安全性を高めています。最終用途分野には、病院、在宅ヘルスケア、薬局などが含まれます。市場成長に影響を与える主な要因としては、慢性疾患の増加、医薬品流通の規制遵守、投薬ミスの削減の推進などが挙げられます。在宅ヘルスケアサービスの動向の高まりと、自動単位用量パッケージング技術の先進は、市場に潜在的な機会をもたらしています。特に、スマート包装と自動調剤システムにおける技術革新は、投資の機が熟している分野です。しかし市場は、初期導入コストの高さや、厳格な遵守が求められる複雑な規制状況などの制約に直面しています。さらに、先端技術の統合には熟練した人材が必要であり、専門的なヘルスケア領域における労働力の格差を考えると、これは困難な課題となりうる。技術革新と研究は、費用対効果が高く効率的なパッケージング・ソリューションの開発と、服薬アドヒアランスの追跡と監視を強化するデジタルヘルス技術の統合に重点を置く必要があります。市場の競争は激しく、各社は技術力の強化とサービス・ポートフォリオの拡大を競っています。今後の成長の道筋としては、個別化医療や、より良い在庫管理と患者の転帰のためのリアルタイムのデータ分析を促進する技術などが考えられます。単位投与量製造産業で資本獲得を目指す企業にとって、新たな業界動向に合わせて製品を提供し、規制の俊敏性に焦点を当て、業界標準と消費者の期待の両方を満たす持続可能なパッケージング・ソリューションに投資することが重要です。

市場力学：急速に進化する単位投与量製造市場の主要市場インサイトを公開

単位投与量製造市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができ、また、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 投薬ミスを減らすための単位用量の採用増加
  • 再包装よりも単位用量製造の方が優れているという認識の高まり
  • 製薬業界の急速な発展
• 市場抑制要因
  • 原材料価格の変動
• 市場機会
  • 革新的な包装技術と送達ソリューション
  • 固形製剤の連続製造（CM）の採用
• 市場の課題
  • 製造単位用量の採用に伴う問題

ポーターの5つの力：単位投与量製造市場をナビゲートする戦略ツール

ポーターの5つの力」フレームワークは、市場情勢の競合情勢を把握するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：単位投与量製造市場における外部からの影響の把握

外部マクロ環境要因は、単位投与量製造市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析単位投与量製造市場における競合情勢の把握

単位投与量製造市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス単位投与量製造市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、単位投与量製造市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によりベンダーを明確かつ的確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨単位投与量製造市場における成功への道筋を描く

単位投与量製造市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を検討することで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 投薬ミスを減らすために単位用量の採用を増やす
    • 再包装よりも単位用量の製造のメリットに対する認識の高まり
    • 製薬業界の急速な発展
  • 抑制要因
    • 原材料価格の変動
  • 機会
    • 革新的な包装技術と配送ソリューション
    • 固形製剤の連続製造（CM）の採用
  • 課題
    • 製造された単位用量の採用に関連する問題
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 単位投与量製造市場：製品別

• 液体単位用量
• 固形単位用量

第7章 単位投与量製造市場調達別

• 社内
• アウトソーシング

第8章 単位投与量製造市場：エンドユーザー別

• 病院
• 独立薬局
• 長期ケア施設

第9章 南北アメリカの単位投与量製造市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋地域の単位投与量製造市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカの単位投与量製造市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Amcor PLC
• American Health Packaging
• Catalent Inc.
• Cencora, Inc.
• Corden Pharma GmbH
• Medical Packaging Inc., LLC
• Mikart, LLC
• Patheon by Thermo Fisher Scientific Inc.
• The Tapemark Company by LTS Lohmann Therapie-Systeme AG
• Unither Pharmaceuticals SAS

LIST OF FIGURES

• FIGURE 1. UNIT DOSE MANUFACTURING MARKET RESEARCH PROCESS
• FIGURE 2. UNIT DOSE MANUFACTURING MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL UNIT DOSE MANUFACTURING MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL UNIT DOSE MANUFACTURING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL UNIT DOSE MANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL UNIT DOSE MANUFACTURING MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL UNIT DOSE MANUFACTURING MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL UNIT DOSE MANUFACTURING MARKET SIZE, BY SOURCING, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL UNIT DOSE MANUFACTURING MARKET SIZE, BY SOURCING, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL UNIT DOSE MANUFACTURING MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL UNIT DOSE MANUFACTURING MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS UNIT DOSE MANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 13. AMERICAS UNIT DOSE MANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. UNITED STATES UNIT DOSE MANUFACTURING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 15. UNITED STATES UNIT DOSE MANUFACTURING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC UNIT DOSE MANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. ASIA-PACIFIC UNIT DOSE MANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. EUROPE, MIDDLE EAST & AFRICA UNIT DOSE MANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA UNIT DOSE MANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. UNIT DOSE MANUFACTURING MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 21. UNIT DOSE MANUFACTURING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. UNIT DOSE MANUFACTURING MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL UNIT DOSE MANUFACTURING MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL UNIT DOSE MANUFACTURING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL UNIT DOSE MANUFACTURING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. UNIT DOSE MANUFACTURING MARKET DYNAMICS
• TABLE 7. GLOBAL UNIT DOSE MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL UNIT DOSE MANUFACTURING MARKET SIZE, BY LIQUID UNIT DOSE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL UNIT DOSE MANUFACTURING MARKET SIZE, BY SOLID UNIT DOSE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL UNIT DOSE MANUFACTURING MARKET SIZE, BY SOURCING, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL UNIT DOSE MANUFACTURING MARKET SIZE, BY IN-HOUSE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL UNIT DOSE MANUFACTURING MARKET SIZE, BY OUTSOURCING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL UNIT DOSE MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL UNIT DOSE MANUFACTURING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL UNIT DOSE MANUFACTURING MARKET SIZE, BY INDEPENDENT PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL UNIT DOSE MANUFACTURING MARKET SIZE, BY LONG TERM CARE FACILITY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. AMERICAS UNIT DOSE MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 18. AMERICAS UNIT DOSE MANUFACTURING MARKET SIZE, BY SOURCING, 2018-2030 (USD MILLION)
• TABLE 19. AMERICAS UNIT DOSE MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 20. AMERICAS UNIT DOSE MANUFACTURING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 21. ARGENTINA UNIT DOSE MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 22. ARGENTINA UNIT DOSE MANUFACTURING MARKET SIZE, BY SOURCING, 2018-2030 (USD MILLION)
• TABLE 23. ARGENTINA UNIT DOSE MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 24. BRAZIL UNIT DOSE MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 25. BRAZIL UNIT DOSE MANUFACTURING MARKET SIZE, BY SOURCING, 2018-2030 (USD MILLION)
• TABLE 26. BRAZIL UNIT DOSE MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 27. CANADA UNIT DOSE MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 28. CANADA UNIT DOSE MANUFACTURING MARKET SIZE, BY SOURCING, 2018-2030 (USD MILLION)
• TABLE 29. CANADA UNIT DOSE MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 30. MEXICO UNIT DOSE MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 31. MEXICO UNIT DOSE MANUFACTURING MARKET SIZE, BY SOURCING, 2018-2030 (USD MILLION)
• TABLE 32. MEXICO UNIT DOSE MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 33. UNITED STATES UNIT DOSE MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 34. UNITED STATES UNIT DOSE MANUFACTURING MARKET SIZE, BY SOURCING, 2018-2030 (USD MILLION)
• TABLE 35. UNITED STATES UNIT DOSE MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 36. UNITED STATES UNIT DOSE MANUFACTURING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 37. ASIA-PACIFIC UNIT DOSE MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 38. ASIA-PACIFIC UNIT DOSE MANUFACTURING MARKET SIZE, BY SOURCING, 2018-2030 (USD MILLION)
• TABLE 39. ASIA-PACIFIC UNIT DOSE MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 40. ASIA-PACIFIC UNIT DOSE MANUFACTURING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 41. AUSTRALIA UNIT DOSE MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 42. AUSTRALIA UNIT DOSE MANUFACTURING MARKET SIZE, BY SOURCING, 2018-2030 (USD MILLION)
• TABLE 43. AUSTRALIA UNIT DOSE MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 44. CHINA UNIT DOSE MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 45. CHINA UNIT DOSE MANUFACTURING MARKET SIZE, BY SOURCING, 2018-2030 (USD MILLION)
• TABLE 46. CHINA UNIT DOSE MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 47. INDIA UNIT DOSE MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 48. INDIA UNIT DOSE MANUFACTURING MARKET SIZE, BY SOURCING, 2018-2030 (USD MILLION)
• TABLE 49. INDIA UNIT DOSE MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 50. INDONESIA UNIT DOSE MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 51. INDONESIA UNIT DOSE MANUFACTURING MARKET SIZE, BY SOURCING, 2018-2030 (USD MILLION)
• TABLE 52. INDONESIA UNIT DOSE MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 53. JAPAN UNIT DOSE MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 54. JAPAN UNIT DOSE MANUFACTURING MARKET SIZE, BY SOURCING, 2018-2030 (USD MILLION)
• TABLE 55. JAPAN UNIT DOSE MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 56. MALAYSIA UNIT DOSE MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 57. MALAYSIA UNIT DOSE MANUFACTURING MARKET SIZE, BY SOURCING, 2018-2030 (USD MILLION)
• TABLE 58. MALAYSIA UNIT DOSE MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 59. PHILIPPINES UNIT DOSE MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 60. PHILIPPINES UNIT DOSE MANUFACTURING MARKET SIZE, BY SOURCING, 2018-2030 (USD MILLION)
• TABLE 61. PHILIPPINES UNIT DOSE MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 62. SINGAPORE UNIT DOSE MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 63. SINGAPORE UNIT DOSE MANUFACTURING MARKET SIZE, BY SOURCING, 2018-2030 (USD MILLION)
• TABLE 64. SINGAPORE UNIT DOSE MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 65. SOUTH KOREA UNIT DOSE MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 66. SOUTH KOREA UNIT DOSE MANUFACTURING MARKET SIZE, BY SOURCING, 2018-2030 (USD MILLION)
• TABLE 67. SOUTH KOREA UNIT DOSE MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 68. TAIWAN UNIT DOSE MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 69. TAIWAN UNIT DOSE MANUFACTURING MARKET SIZE, BY SOURCING, 2018-2030 (USD MILLION)
• TABLE 70. TAIWAN UNIT DOSE MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 71. THAILAND UNIT DOSE MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 72. THAILAND UNIT DOSE MANUFACTURING MARKET SIZE, BY SOURCING, 2018-2030 (USD MILLION)
• TABLE 73. THAILAND UNIT DOSE MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 74. VIETNAM UNIT DOSE MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 75. VIETNAM UNIT DOSE MANUFACTURING MARKET SIZE, BY SOURCING, 2018-2030 (USD MILLION)
• TABLE 76. VIETNAM UNIT DOSE MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 77. EUROPE, MIDDLE EAST & AFRICA UNIT DOSE MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 78. EUROPE, MIDDLE EAST & AFRICA UNIT DOSE MANUFACTURING MARKET SIZE, BY SOURCING, 2018-2030 (USD MILLION)
• TABLE 79. EUROPE, MIDDLE EAST & AFRICA UNIT DOSE MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 80. EUROPE, MIDDLE EAST & AFRICA UNIT DOSE MANUFACTURING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 81. DENMARK UNIT DOSE MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 82. DENMARK UNIT DOSE MANUFACTURING MARKET SIZE, BY SOURCING, 2018-2030 (USD MILLION)
• TABLE 83. DENMARK UNIT DOSE MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 84. EGYPT UNIT DOSE MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 85. EGYPT UNIT DOSE MANUFACTURING MARKET SIZE, BY SOURCING, 2018-2030 (USD MILLION)
• TABLE 86. EGYPT UNIT DOSE MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 87. FINLAND UNIT DOSE MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 88. FINLAND UNIT DOSE MANUFACTURING MARKET SIZE, BY SOURCING, 2018-2030 (USD MILLION)
• TABLE 89. FINLAND UNIT DOSE MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 90. FRANCE UNIT DOSE MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 91. FRANCE UNIT DOSE MANUFACTURING MARKET SIZE, BY SOURCING, 2018-2030 (USD MILLION)
• TABLE 92. FRANCE UNIT DOSE MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 93. GERMANY UNIT DOSE MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 94. GERMANY UNIT DOSE MANUFACTURING MARKET SIZE, BY SOURCING, 2018-2030 (USD MILLION)
• TABLE 95. GERMANY UNIT DOSE MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 96. ISRAEL UNIT DOSE MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 97. ISRAEL UNIT DOSE MANUFACTURING MARKET SIZE, BY SOURCING, 2018-2030 (USD MILLION)
• TABLE 98. ISRAEL UNIT DOSE MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 99. ITALY UNIT DOSE MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 100. ITALY UNIT DOSE MANUFACTURING MARKET SIZE, BY SOURCING, 2018-2030 (USD MILLION)
• TABLE 101. ITALY UNIT DOSE MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 102. NETHERLANDS UNIT DOSE MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 103. NETHERLANDS UNIT DOSE MANUFACTURING MARKET SIZE, BY SOURCING, 2018-2030 (USD MILLION)
• TABLE 104. NETHERLANDS UNIT DOSE MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 105. NIGERIA UNIT DOSE MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 106. NIGERIA UNIT DOSE MANUFACTURING MARKET SIZE, BY SOURCING, 2018-2030 (USD MILLION)
• TABLE 107. NIGERIA UNIT DOSE MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 108. NORWAY UNIT DOSE MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 109. NORWAY UNIT DOSE MANUFACTURING MARKET SIZE, BY SOURCING, 2018-2030 (USD MILLION)
• TABLE 110. NORWAY UNIT DOSE MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 111. POLAND UNIT DOSE MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 112. POLAND UNIT DOSE MANUFACTURING MARKET SIZE, BY SOURCING, 2018-2030 (USD MILLION)
• TABLE 113. POLAND UNIT DOSE MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 114. QATAR UNIT DOSE MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 115. QATAR UNIT DOSE MANUFACTURING MARKET SIZE, BY SOURCING, 2018-2030 (USD MILLION)
• TABLE 116. QATAR UNIT DOSE MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 117. RUSSIA UNIT DOSE MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 118. RUSSIA UNIT DOSE MANUFACTURING MARKET SIZE, BY SOURCING, 2018-2030 (USD MILLION)
• TABLE 119. RUSSIA UNIT DOSE MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 120. SAUDI ARABIA UNIT DOSE MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 121. SAUDI ARABIA UNIT DOSE MANUFACTURING MARKET SIZE, BY SOURCING, 2018-2030 (USD MILLION)
• TABLE 122. SAUDI ARABIA UNIT DOSE MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 123. SOUTH AFRICA UNIT DOSE MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 124. SOUTH AFRICA UNIT DOSE MANUFACTURING MARKET SIZE, BY SOURCING, 2018-2030 (USD MILLION)
• TABLE 125. SOUTH AFRICA UNIT DOSE MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 126. SPAIN UNIT DOSE MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 127. SPAIN UNIT DOSE MANUFACTURING MARKET SIZE, BY SOURCING, 2018-2030 (USD MILLION)
• TABLE 128. SPAIN UNIT DOSE MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 129. SWEDEN UNIT DOSE MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 130. SWEDEN UNIT DOSE MANUFACTURING MARKET SIZE, BY SOURCING, 2018-2030 (USD MILLION)
• TABLE 131. SWEDEN UNIT DOSE MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 132. SWITZERLAND UNIT DOSE MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 133. SWITZERLAND UNIT DOSE MANUFACTURING MARKET SIZE, BY SOURCING, 2018-2030 (USD MILLION)
• TABLE 134. SWITZERLAND UNIT DOSE MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 135. TURKEY UNIT DOSE MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 136. TURKEY UNIT DOSE MANUFACTURING MARKET SIZE, BY SOURCING, 2018-2030 (USD MILLION)
• TABLE 137. TURKEY UNIT DOSE MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 138. UNITED ARAB EMIRATES UNIT DOSE MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 139. UNITED ARAB EMIRATES UNIT DOSE MANUFACTURING MARKET SIZE, BY SOURCING, 2018-2030 (USD MILLION)
• TABLE 140. UNITED ARAB EMIRATES UNIT DOSE MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 141. UNITED KINGDOM UNIT DOSE MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 142. UNITED KINGDOM UNIT DOSE MANUFACTURING MARKET SIZE, BY SOURCING, 2018-2030 (USD MILLION)
• TABLE 143. UNITED KINGDOM UNIT DOSE MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 144. UNIT DOSE MANUFACTURING MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 145. UNIT DOSE MANUFACTURING MARKET, FPNV POSITIONING MATRIX, 2023

The Unit Dose Manufacturing Market was valued at USD 23.34 billion in 2023, expected to reach USD 27.61 billion in 2024, and is projected to grow at a CAGR of 18.76%, to USD 77.81 billion by 2030.

Unit Dose Manufacturing involves the production of pre-measured, individualized doses of medications and is a vital component within the healthcare and pharmaceutical industries. Its necessity is emphasized by the growing demand for effective medication management, patient safety, and adherence to prescribed therapies, especially in hospitals and long-term care facilities. Applications extend beyond pharmaceuticals into nutraceuticals and over-the-counter medications, leveraging unit doses for precision and safety. End-use sectors include hospitals, home healthcare, and pharmacies. Key factors influencing market growth include increasing chronic disease prevalence, regulatory compliance for medication distribution, and the push for reduced medication errors. The growing trend of home healthcare services and the advancement of automated unit dose packaging technologies present potential opportunities for the market. Notably, technological innovations in smart packaging and automated dispensing systems are areas ripe for investment. However, the market faces limitations such as high initial implementation costs and a complex regulatory landscape that demands rigorous adherence. Moreover, the integration of advanced technologies requires skilled personnel, which can be a challenging factor given the workforce gap in specialized healthcare domains. Innovation and research should focus on developing cost-effective, efficient packaging solutions and integrating digital health technologies that enhance tracking and monitoring of medication adherence. The market's nature is competitive, with companies vying to enhance their technological capabilities and expand their service portfolios. Future growth avenues may include personalized medicine and technologies that facilitate real-time data analytics for better inventory management and patient outcomes. For companies aiming to capitalize on the unit dose manufacturing industry, it is critical to align product offerings with emerging industry trends, focus on regulatory agility, and invest in sustainable packaging solutions that meet both industry standards and consumer expectations.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Unit Dose Manufacturing Market

The Unit Dose Manufacturing Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing adoption of unit doses to reduce medication errors
  • Rising awareness of benefits of manufacturing unit doses over repackaging
  • Rapid development in the pharmaceutical industry
• Market Restraints
  • Fluctuations in the prices of raw materials
• Market Opportunities
  • Innovative packaging technologies and delivery solutions
  • Adopting continuous manufacturing (CM) for solid-dose drug products
• Market Challenges
  • Issues associated with the adoption of manufactured unit doses

Porter's Five Forces: A Strategic Tool for Navigating the Unit Dose Manufacturing Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Unit Dose Manufacturing Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Unit Dose Manufacturing Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Unit Dose Manufacturing Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Unit Dose Manufacturing Market

A detailed market share analysis in the Unit Dose Manufacturing Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Unit Dose Manufacturing Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Unit Dose Manufacturing Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Unit Dose Manufacturing Market

A strategic analysis of the Unit Dose Manufacturing Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Unit Dose Manufacturing Market, highlighting leading vendors and their innovative profiles. These include Amcor PLC, American Health Packaging, Catalent Inc., Cencora, Inc., Corden Pharma GmbH, Medical Packaging Inc., LLC, Mikart, LLC, Patheon by Thermo Fisher Scientific Inc., The Tapemark Company by LTS Lohmann Therapie-Systeme AG, and Unither Pharmaceuticals SAS.

Market Segmentation & Coverage

This research report categorizes the Unit Dose Manufacturing Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product, market is studied across Liquid Unit Dose and Solid Unit Dose.
• Based on Sourcing, market is studied across In-House and Outsourcing.
• Based on End-User, market is studied across Hospitals, Independent Pharmacies, and Long Term Care Facility.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing adoption of unit doses to reduce medication errors
    • 5.1.1.2. Rising awareness of benefits of manufacturing unit doses over repackaging
    • 5.1.1.3. Rapid development in the pharmaceutical industry
  • 5.1.2. Restraints
    • 5.1.2.1. Fluctuations in the prices of raw materials
  • 5.1.3. Opportunities
    • 5.1.3.1. Innovative packaging technologies and delivery solutions
    • 5.1.3.2. Adopting continuous manufacturing (CM) for solid-dose drug products
  • 5.1.4. Challenges
    • 5.1.4.1. Issues associated with the adoption of manufactured unit doses
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Unit Dose Manufacturing Market, by Product

• 6.1. Introduction
• 6.2. Liquid Unit Dose
• 6.3. Solid Unit Dose

7. Unit Dose Manufacturing Market, by Sourcing

• 7.1. Introduction
• 7.2. In-House
• 7.3. Outsourcing

8. Unit Dose Manufacturing Market, by End-User

• 8.1. Introduction
• 8.2. Hospitals
• 8.3. Independent Pharmacies
• 8.4. Long Term Care Facility

9. Americas Unit Dose Manufacturing Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Unit Dose Manufacturing Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Unit Dose Manufacturing Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Amcor PLC
• 2. American Health Packaging
• 3. Catalent Inc.
• 4. Cencora, Inc.
• 5. Corden Pharma GmbH
• 6. Medical Packaging Inc., LLC
• 7. Mikart, LLC
• 8. Patheon by Thermo Fisher Scientific Inc.
• 9. The Tapemark Company by LTS Lohmann Therapie-Systeme AG
• 10. Unither Pharmaceuticals SAS